Pathogenic DDX3X Mutations Impair RNA Metabolism and Neurogenesis during Fetal Cortical Development.


Journal

Neuron
ISSN: 1097-4199
Titre abrégé: Neuron
Pays: United States
ID NLM: 8809320

Informations de publication

Date de publication:
06 05 2020
Historique:
received: 10 05 2018
revised: 05 11 2019
accepted: 29 01 2020
pubmed: 7 3 2020
medline: 25 8 2020
entrez: 6 3 2020
Statut: ppublish

Résumé

De novo germline mutations in the RNA helicase DDX3X account for 1%-3% of unexplained intellectual disability (ID) cases in females and are associated with autism, brain malformations, and epilepsy. Yet, the developmental and molecular mechanisms by which DDX3X mutations impair brain function are unknown. Here, we use human and mouse genetics and cell biological and biochemical approaches to elucidate mechanisms by which pathogenic DDX3X variants disrupt brain development. We report the largest clinical cohort to date with DDX3X mutations (n = 107), demonstrating a striking correlation between recurrent dominant missense mutations, polymicrogyria, and the most severe clinical outcomes. We show that Ddx3x controls cortical development by regulating neuron generation. Severe DDX3X missense mutations profoundly disrupt RNA helicase activity, induce ectopic RNA-protein granules in neural progenitors and neurons, and impair translation. Together, these results uncover key mechanisms underlying DDX3X syndrome and highlight aberrant RNA metabolism in the pathogenesis of neurodevelopmental disease.

Identifiants

pubmed: 32135084
pii: S0896-6273(20)30099-4
doi: 10.1016/j.neuron.2020.01.042
pmc: PMC7331285
mid: NIHMS1572732
pii:
doi:

Substances chimiques

RNA 63231-63-0
DDX3X protein, human EC 3.6.1.-
DEAD-box RNA Helicases EC 3.6.4.13

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

404-420.e8

Subventions

Organisme : NINDS NIH HHS
ID : R21 NS098176
Pays : United States
Organisme : NIGMS NIH HHS
ID : DP2 GM132932
Pays : United States
Organisme : NIGMS NIH HHS
ID : T32 GM007184
Pays : United States
Organisme : NIGMS NIH HHS
ID : T32 GM007618
Pays : United States
Organisme : NINDS NIH HHS
ID : F32 NS112566
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS110388
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS050375
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS083897
Pays : United States
Organisme : NINDS NIH HHS
ID : F31 NS093762
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS058721
Pays : United States

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Interests The authors declare no competing interests.

Références

Nat Genet. 2015 Sep;47(9):1061-6
pubmed: 26192917
Nucleic Acids Res. 2021 May 21;49(9):5336-5350
pubmed: 33905506
Methods Mol Biol. 2010;587:245-64
pubmed: 20225155
Science. 2017 Dec 8;358(6368):1318-1323
pubmed: 29217575
Cold Spring Harb Perspect Biol. 2012 Jul 01;4(7):a008094
pubmed: 22621768
AJNR Am J Neuroradiol. 2009 Jun;30(6):1142-8
pubmed: 19246528
Wiley Interdiscip Rev RNA. 2013 Jul-Aug;4(4):369-85
pubmed: 23606618
Neuron. 2014 Nov 19;84(4):723-39
pubmed: 25456498
Curr Opin Chem Biol. 2013 Oct;17(5):738-46
pubmed: 23938204
EMBO Rep. 2019 Sep;20(9):e47498
pubmed: 31347257
Hum Genomics. 2018 Mar 1;12(1):11
pubmed: 29490693
Nucleic Acids Res. 2004 Jan 1;32(Database issue):D552-6
pubmed: 14681479
Clin Dysmorphol. 2019 Oct;28(4):169-174
pubmed: 31274575
Proc Natl Acad Sci U S A. 2013 Oct 1;110(40):16205-10
pubmed: 24043809
Oncotarget. 2016 May 10;7(19):28169-82
pubmed: 27058758
Proc Natl Acad Sci U S A. 2018 Dec 18;115(51):13015-13020
pubmed: 30510006
AJR Am J Roentgenol. 2006 Nov;187(5):1343-8
pubmed: 17056927
Am J Hum Genet. 2019 Sep 5;105(3):509-525
pubmed: 31422817
Cell Rep. 2018 Jan 16;22(3):734-747
pubmed: 29346770
Neuron. 2019 Dec 4;104(5):885-898.e8
pubmed: 31587919
Am J Hum Genet. 2017 Jul 6;101(1):23-36
pubmed: 28625504
J Biomed Res. 2014 Jul;28(4):282-91
pubmed: 25050112
Neuron. 2011 Feb 10;69(3):482-97
pubmed: 21315259
Nat Commun. 2017 Oct 27;8(1):1158
pubmed: 29079819
Pediatr Clin North Am. 2015 Jun;62(3):571-85
pubmed: 26022163
Ann Clin Transl Neurol. 2018 Sep 15;5(10):1277-1285
pubmed: 30349862
Cell Stem Cell. 2019 Sep 5;25(3):433-446.e7
pubmed: 31204176
Cancer Res. 2018 Aug 15;78(16):4512-4523
pubmed: 29921696
Am J Med Genet A. 2016 Oct;170(10):2551-8
pubmed: 27510950
Biochim Biophys Acta. 2016 Jun;1863(6 Pt A):1093-105
pubmed: 26876306
Cell. 2019 Aug 8;178(4):850-866.e26
pubmed: 31398340
Proc Natl Acad Sci U S A. 2011 Jul 19;108(29):12007-12
pubmed: 21730191
Am J Hum Genet. 2017 Nov 2;101(5):716-724
pubmed: 29100085
Neuron. 2015 Jan 21;85(2):275-288
pubmed: 25556833
Sci Rep. 2016 May 16;6:25996
pubmed: 27180681
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
Cell. 2018 Jan 25;172(3):590-604.e13
pubmed: 29373831
Wiley Interdiscip Rev Dev Biol. 2018 Jan;7(1):
pubmed: 28837264
Crit Rev Biochem Mol Biol. 2014 Jul-Aug;49(4):343-60
pubmed: 25039764
Nat Protoc. 2006;1(3):1552-8
pubmed: 17406448
Nature. 2012 Aug 2;488(7409):100-5
pubmed: 22832583
Eur J Hum Genet. 2019 Aug;27(8):1254-1259
pubmed: 30936465
PLoS Genet. 2016 Sep 12;12(9):e1006282
pubmed: 27618312
J Biol Chem. 2016 Jan 29;291(5):2412-21
pubmed: 26598523
AJNR Am J Neuroradiol. 2003 May;24(5):788-93
pubmed: 12748072
Hum Mol Genet. 2016 Jul 15;25(14):2905-2922
pubmed: 27179789
Nature. 2012 Aug 2;488(7409):43-8
pubmed: 22722829
Nature. 2014 Apr 10;508(7495):199-206
pubmed: 24695229
Cell. 2013 Aug 15;154(4):727-36
pubmed: 23953108
Biochem J. 2012 Jan 1;441(1):119-29
pubmed: 21883093
Neuron. 2004 Aug 19;43(4):513-25
pubmed: 15312650
Proc Natl Acad Sci U S A. 2011 Sep 6;108(36):14950-5
pubmed: 21873192
Mol Biol Cell. 2008 Sep;19(9):3847-58
pubmed: 18596238
Nat Neurosci. 2017 Apr;20(4):602-611
pubmed: 28263302
Cell Rep. 2019 Jun 18;27(12):3573-3586.e7
pubmed: 31216476
Am J Hum Genet. 2015 Aug 6;97(2):343-52
pubmed: 26235985
J Neurosci. 2015 May 6;35(18):7003-18
pubmed: 25948253
Nature. 2014 Nov 13;515(7526):216-21
pubmed: 25363768
Annu Rev Cell Dev Biol. 2014;30:465-502
pubmed: 25000993
BMC Dev Biol. 2010 Dec 21;10:121
pubmed: 21176145
Nature. 2019 Sep;573(7775):590-594
pubmed: 31511697
Am J Med Genet A. 2017 May;173(5):1369-1373
pubmed: 28371085
Protein Sci. 2016 Mar;25(3):638-49
pubmed: 26650549
Trends Neurosci. 2011 Jan;34(1):41-50
pubmed: 21129791
Nature. 2012 Aug 2;488(7409):106-10
pubmed: 22820256
Nature. 2019 Sep;573(7772):144-148
pubmed: 31435012
EMBO J. 1999 Dec 1;18(23):6705-17
pubmed: 10581244
Nat Methods. 2012 Jul;9(7):671-5
pubmed: 22930834
Science. 2013 Feb 15;339(6121):819-23
pubmed: 23287718
Neuron. 2019 Sep 4;103(5):785-801.e8
pubmed: 31303374
Nat Methods. 2009 Apr;6(4):275-7
pubmed: 19305406
Oncogene. 2008 Jan 24;27(5):700-14
pubmed: 17667941
Nature. 2005 Mar 17;434(7031):400-4
pubmed: 15772666
Science. 2013 Mar 22;339(6126):1436-41
pubmed: 23413191
J Neurosci. 2015 Nov 25;35(47):15666-81
pubmed: 26609159
Mol Cell Proteomics. 2006 Apr;5(4):635-51
pubmed: 16352523

Auteurs

Ashley L Lennox (AL)

Department of Molecular Genetics and Microbiology, Duke University Medical Center, Durham, NC 27710, USA.

Mariah L Hoye (ML)

Department of Molecular Genetics and Microbiology, Duke University Medical Center, Durham, NC 27710, USA.

Ruiji Jiang (R)

Department of Neurology, University of California, San Francisco, San Francisco, CA 94158, USA.

Bethany L Johnson-Kerner (BL)

Department of Neurology, University of California, San Francisco, San Francisco, CA 94158, USA.

Lindsey A Suit (LA)

Department of Neurology, University of California, San Francisco, San Francisco, CA 94158, USA.

Srivats Venkataramanan (S)

Department of Cell and Tissue Biology, University of California, San Francisco, San Francisco, CA 94158, USA.

Charles J Sheehan (CJ)

Department of Molecular Genetics and Microbiology, Duke University Medical Center, Durham, NC 27710, USA.

Fernando C Alsina (FC)

Department of Molecular Genetics and Microbiology, Duke University Medical Center, Durham, NC 27710, USA.

Brieana Fregeau (B)

Department of Neurology, University of California, San Francisco, San Francisco, CA 94158, USA.

Kimberly A Aldinger (KA)

Center for Integrative Brain Research, Seattle Children's Research Institute, Seattle, WA 98101, USA.

Ching Moey (C)

The University of Queensland, Queensland Brain Institute, Brisbane, QLD 4072, Australia.

Iryna Lobach (I)

Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA 94158, USA.

Alexandra Afenjar (A)

Centre de référence des malformations et maladies congénitales du cervelet et Département de génétique et embryologie médicale, APHP, Sorbonne Université, Hôpital Armand Trousseau, 75012 Paris, France.

Dusica Babovic-Vuksanovic (D)

Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905, USA; Department of Clinical Genomics, Mayo Clinic, Rochester, MN 55905, USA; Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, MN 55905, USA.

Stéphane Bézieau (S)

Service de Génétique Médicale, CHU Nantes, 9 quai Moncousu, 44093 Nantes Cedex 1, France; Université de Nantes, CNRS, INSERM, l'institut du thorax, 44000 Nantes, France.

Patrick R Blackburn (PR)

Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905, USA; Center for Individualized Medicine, Mayo Clinic, Rochester, MN 55905, USA.

Jens Bunt (J)

The University of Queensland, Queensland Brain Institute, Brisbane, QLD 4072, Australia.

Lydie Burglen (L)

Centre de référence des malformations et maladies congénitales du cervelet et Département de génétique et embryologie médicale, APHP, Sorbonne Université, Hôpital Armand Trousseau, 75012 Paris, France.

Philippe M Campeau (PM)

Department of Pediatrics, University of Montreal and CHU Sainte-Justine, Montreal, QC, Canada.

Perrine Charles (P)

Département de Génétique, Centre de Référence Déficiences Intellectuelles de Causes Rares, Groupe Hospitalier Pitié Salpêtrière et Hôpital Trousseau, APHP, Sorbonne Université, Paris, France.

Brian H Y Chung (BHY)

Department of Paediatrics and Adolescent Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China.

Benjamin Cogné (B)

Service de Génétique Médicale, CHU Nantes, 9 quai Moncousu, 44093 Nantes Cedex 1, France; Université de Nantes, CNRS, INSERM, l'institut du thorax, 44000 Nantes, France.

Cynthia Curry (C)

Genetic Medicine, University of California San Francisco/Fresno, Fresno, CA 93701, USA.

Maria Daniela D'Agostino (MD)

Division of Medical Genetics, Departments of Specialized Medicine and Human Genetics, McGill University, Montreal, QC, Canada.

Nataliya Di Donato (N)

Institute for Clinical Genetics, TU Dresden, Dresden, Germany.

Laurence Faivre (L)

Centre de référence Anomalies du Développement et Syndromes Malformatifs, INSERM UMR 1231 GAD, CHU de Dijon et Université de Bourgogne, Dijon, France.

Delphine Héron (D)

APHP, Département de Génétique, Groupe Hospitalier Pitié Salpêtrière, Paris, France.

A Micheil Innes (AM)

Department of Medical Genetics, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.

Bertrand Isidor (B)

Service de Génétique Médicale, CHU Nantes, 9 quai Moncousu, 44093 Nantes Cedex 1, France; Université de Nantes, CNRS, INSERM, l'institut du thorax, 44000 Nantes, France.

Boris Keren (B)

APHP, Département de Génétique, Groupe Hospitalier Pitié Salpêtrière, Paris, France.

Amy Kimball (A)

Harvey Institute of Human Genetics, Greater Baltimore Medical Center, Baltimore, MD, USA.

Eric W Klee (EW)

Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905, USA; Department of Clinical Genomics, Mayo Clinic, Rochester, MN 55905, USA; Center for Individualized Medicine, Mayo Clinic, Rochester, MN 55905, USA; Department of Health Sciences Research, Mayo Clinic, Rochester, MN 55905, USA.

Paul Kuentz (P)

UMR-INSERM 1231 GAD, Génétique des Anomalies du développement, Université de Bourgogne Franche-Comté, Dijon, France.

Sébastien Küry (S)

Service de Génétique Médicale, CHU Nantes, 9 quai Moncousu, 44093 Nantes Cedex 1, France; Université de Nantes, CNRS, INSERM, l'institut du thorax, 44000 Nantes, France.

Dominique Martin-Coignard (D)

Service de Génétique, Centre hospitalier du Mans, Le Mans, France.

Ghayda Mirzaa (G)

Center for Integrative Brain Research, Seattle Children's Research Institute, Seattle, WA 98101, USA; Department of Pediatrics, University of Washington, Seattle, WA 98101, USA.

Cyril Mignot (C)

Département de Génétique, Centre de Référence Déficiences Intellectuelles de Causes Rares, Groupe Hospitalier Pitié Salpêtrière et Hôpital Trousseau, APHP, Sorbonne Université, Paris, France.

Noriko Miyake (N)

Department of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama 236-0004, Japan.

Naomichi Matsumoto (N)

Department of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama 236-0004, Japan.

Atsushi Fujita (A)

Department of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama 236-0004, Japan.

Caroline Nava (C)

APHP, Département de Génétique, Groupe Hospitalier Pitié Salpêtrière, Paris, France.

Mathilde Nizon (M)

Service de Génétique Médicale, CHU Nantes, 9 quai Moncousu, 44093 Nantes Cedex 1, France; Université de Nantes, CNRS, INSERM, l'institut du thorax, 44000 Nantes, France.

Diana Rodriguez (D)

Centre de Référence Neurogénétique & Service de Neurologie Pédiatrique, APHP, Sorbonne Université, Hôpital Armand Trousseau, 75012 Paris, France.

Lot Snijders Blok (LS)

Department of Human Genetics, Radboud University Medical Center, 6500 HB Nijmegen, the Netherlands.

Christel Thauvin-Robinet (C)

Centre de référence Déficience Intellectuelle, INSERM UMR 1231 GAD, CHU de Dijon et Université de Bourgogne, Dijon, France.

Julien Thevenon (J)

Centre de référence Anomalies du Développement et Syndromes Malformatifs, INSERM UMR 1231 GAD, CHU de Dijon et Université de Bourgogne, Dijon, France.

Marie Vincent (M)

Service de Génétique Médicale, CHU Nantes, 9 quai Moncousu, 44093 Nantes Cedex 1, France; Université de Nantes, CNRS, INSERM, l'institut du thorax, 44000 Nantes, France.

Alban Ziegler (A)

Service de Génétique, CHU d'Angers, Angers, France.

William Dobyns (W)

Center for Integrative Brain Research, Seattle Children's Research Institute, Seattle, WA 98101, USA; Departments of Pediatrics and Neurology, University of Washington, Seattle, WA 98101, USA.

Linda J Richards (LJ)

The University of Queensland, Queensland Brain Institute, Brisbane, QLD 4072, Australia; The University of Queensland, School of Biomedical Sciences, Brisbane 4072, QLD, Australia.

A James Barkovich (AJ)

Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, CA 94158, USA.

Stephen N Floor (SN)

Department of Cell and Tissue Biology, University of California, San Francisco, San Francisco, CA 94158, USA; Helen Diller Family Comprehensive Cancer Center, San Francisco, CA 94158, USA.

Debra L Silver (DL)

Department of Molecular Genetics and Microbiology, Duke University Medical Center, Durham, NC 27710, USA; Department of Cell Biology, Duke University Medical Center, Durham, NC 27710, USA; Department of Neurobiology, Duke University Medical Center, Durham, NC 27710, USA; Duke Institute for Brain Sciences, Duke University, Durham, NC 27710, USA. Electronic address: debra.silver@duke.edu.

Elliott H Sherr (EH)

Department of Neurology, University of California, San Francisco, San Francisco, CA 94158, USA; Institute of Human Genetics and Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA 94158, USA. Electronic address: elliott.sherr@ucsf.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH